Thursday, April 19

2018-04-19 09:00 2018-04-19 17:00 America/New_York PBM Policy Forum Join us for the 2018 PBM Policy Forum at the Newseum in Washington, DC. Washington, DC

The Newseum in Washington, DC

Highlights from last year’s PBM Policy Forum

PBMs’ Role in Clinical Patient Care

William Fleming, Segment PresidentHealthcare Services, Humana Inc.

Surya Singh, Corporate Vice President & Chief Medical Officer, CVS/Specialty, CVS Health

PCMA Leadership Addresses PBM Industry Solutions for High Price Drugs

Mark Merritt, President & Chief Executive Officer, PCMA

PCMA Leadership Discuss Policy Solutions for High Price Drugs

William Fleming, Segment PresidentHealthcare Services, Humana Inc.

Mark Merritt, President & Chief Executive Officer, PCMA

The FDA’s Role in Promoting Competition

Alex Brill, Chief Executive Officer, Matrix Global Advisors & Research Fellow, American Enterprise Institute

About the PBM Policy Forum

With the public debate about prescription drug prices playing out in the press, in Congress, and among regulators, policymakers are focusing on the role of pharmacy benefit managers (PBMs) in addressing drug costs.

Operating under contract with health plan sponsors – insurers and self-funded employer plans alike – PBMs work to lower prescription drug costs for patients.  PBMs negotiate with drug manufacturers and pharmacies to reduce the prices they charge and to establish formularies to encourage plan enrollees to use the most cost-effective drugs.  PBMs also administer prescription drug plans, adjudicating claims in real-time as patients stand at the pharmacy counter to pick up their prescriptions.  In addition, to meet the needs of today’s complex healthcare market, PBMs also help manage clinical care for specialty drugs – usually infused or injected drugs needing special handling and with sometimes hard-to-manage side effects – typically used to treat complex or rare conditions.

PCMA’s PBM Policy Forum will feature policymakers – including key Administration officials and Congressional committee staffers – and PBM executives to discuss how the public and private sectors are tackling drug costs and improving both the affordability and quality of care for patients. Speakers will address topics ranging from applying drug rebates at point of sale, to employer perspectives on the value of PBMs, to clinical and patient programs in specialty pharmacy. We will have perspectives from the Hill, HHS, and FDA, as well as a panel of state legislators.

View the Agenda

Who Should Attend? 

The PCMA PBM Policy Forum is designed for policymakers and staff from Capitol Hill and the Administration, as well as healthcare and drug industry advocates from think tanks, patient advocacy groups, industry trade associations, and the media.

Attendees must register for this free event which has been organized to conform to House and Senate Ethics guidance for widely attended gatherings, with more than 25 individuals from outside organizations in attendance from throughout the industry.

Registered attendees must be affiliated with, and attending this event on  behalf of a company or organization. Please be sure to indicate your affiliation when you register.

All members of the media must check in with PCMA at the registration desk upon arrival at the event.

The PBM Policy Forum will take place at the:

Knight Conference Center at the Newseum
555 Pennsylvania Ave, NW

7th Floor Conference Level

Washington, DC 20001

We do not have a room block for the Policy Forum but recommend some hotels nearby. Please visit the Hotel & Travel page.